These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834 [TBL] [Abstract][Full Text] [Related]
4. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results. Jauković L; Ilić TV; Dopudja M; Ajdinović B Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370 [TBL] [Abstract][Full Text] [Related]
5. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Booij J; Speelman JD; Horstink MW; Wolters EC Eur J Nucl Med; 2001 Mar; 28(3):266-72. PubMed ID: 11315592 [TBL] [Abstract][Full Text] [Related]
6. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575 [TBL] [Abstract][Full Text] [Related]
7. Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease. Benítez-Rivero S; Marín-Oyaga VA; García-Solís D; Huertas-Fernández I; García-Gómez FJ; Jesús S; Cáceres MT; Carrillo F; Ortiz AM; Carballo M; Mir P J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):122-9. PubMed ID: 22906618 [TBL] [Abstract][Full Text] [Related]
8. Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study. Tinazzi M; Morgante F; Matinella A; Bovi T; Cannas A; Solla P; Marrosu F; Nicoletti A; Zappia M; Luca A; Di Stefano A; Morgante L; Pacchetti C; Minafra B; Sciarretta M; Dallocchio C; Rossi S; Ulivelli M; Ceravolo R; Frosini D; Cipriani A; Barbui C Schizophr Res; 2014 Feb; 152(2-3):344-9. PubMed ID: 24369987 [TBL] [Abstract][Full Text] [Related]
9. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298 [TBL] [Abstract][Full Text] [Related]
10. Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism. Lee H; Sung YH; Hwang KH Curr Med Imaging; 2023; 19(9):1041-1051. PubMed ID: 36734891 [TBL] [Abstract][Full Text] [Related]
11. 123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques. Kahraman D; Eggers C; Holstein A; Schneider C; Pedrosa DJ; Dietlein M; Kobe C; Timmermann L; Schmidt M Nuklearmedizin; 2012; 51(6):244-51. PubMed ID: 22526237 [TBL] [Abstract][Full Text] [Related]
14. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365 [TBL] [Abstract][Full Text] [Related]
15. Right putamen and age are the most discriminant features to diagnose Parkinson's disease by using Cascianelli S; Tranfaglia C; Fravolini ML; Bianconi F; Minestrini M; Nuvoli S; Tambasco N; Dottorini ME; Palumbo B Hell J Nucl Med; 2017; 20 Suppl():165. PubMed ID: 29324935 [TBL] [Abstract][Full Text] [Related]
16. [123I]FP-CIT SPECT in Clinically Uncertain Parkinsonism Predicts Survival: A Data-Driven Analysis. Frings L; Henninger F; Treppner M; Köber G; Boeker M; Hellwig S; Buchert R; Meyer PT J Parkinsons Dis; 2020; 10(4):1457-1465. PubMed ID: 33044193 [TBL] [Abstract][Full Text] [Related]
17. 123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study. Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O Nucl Med Commun; 2006 Apr; 27(4):381-6. PubMed ID: 16531926 [TBL] [Abstract][Full Text] [Related]
18. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993 [TBL] [Abstract][Full Text] [Related]